Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Adult hypophosphatasia symptoms often worsen because low alkaline phosphatase activity allows mineral byproducts to build up in bone and soft tissue, weakening the skeleton over years and producing stress fractures, chronic bone and joint pain, muscle weakness, early tooth loss, and fatigue. Escalation is frequently triggered or accelerated by delayed diagnosis, repeated microfractures that fail to heal, vitamin B6 or calcium imbalances, and medications such as bisphosphonates that can be harmful in HPP. Crucial next steps include documenting persistently low serum alkaline phosphatase, testing substrate levels, genetic confirmation of ALPL variants, imaging of suspected fractures, and referral to a metabolic bone specialist who can discuss enzyme replacement therapy. There are several important factors and warning signs to weigh, so see below to understand more before assuming your pain is ordinary arthritis or osteoporosis.
Because adult HPP is commonly mistaken for other conditions for years, mapping your symptoms clearly is the fastest way to ask the right questions at your next appointment, and a free, instant, online symptom check can help you organize what you are feeling and understand which next steps and specialists may fit your situation.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia (HPP) in adulthood is a rare inherited disorder caused by mutations in the ALPL gene, leading to low activity of the tissue-nonspecific alkaline phosphatase (TNSALP) enzyme. This enzyme is essential for proper bone mineralization, muscle function and nerve health. While some adults live with mild symptoms for years, others experience a sudden escalation that can impact daily life. Understanding why symptoms worsen and what to do next empowers you to seek timely care and improve long-term outcomes.
Even if HPP first appears in childhood, many adults face new or intensifying signs:
Escalation of these signs often prompts a re-evaluation of your treatment plan.
Natural bone turnover changes
• Peak bone mass declines with age, so low alkaline phosphatase activity has a greater impact.
• Reduced ability to repair microcracks leads to accumulating bone damage.
Hormonal shifts
• Menopause, testosterone decline or thyroid imbalances can accelerate bone loss.
• Fluctuating hormones may worsen joint pain and muscle symptoms.
Underdiagnosis or misdiagnosis
• Mild adult HPP often goes unrecognized or is mistaken for osteoporosis or fibromyalgia.
• Inappropriate treatments (e.g., bisphosphonates for presumed osteoporosis) can make HPP worse.
Medication interactions
• Some common drugs (proton pump inhibitors, certain anti-seizure medications) can lower bone density.
• Corticosteroids reduce mineralization and may trigger flare-ups.
Lifestyle and comorbidities
• Physical inactivity or repeated high-impact exercise without proper support may strain weakened bones.
• Chronic conditions (diabetes, inflammatory arthritis) can amplify pain and slow healing.
If HPP symptoms worsen without tailored management, you may face:
Prompt action helps you avoid or minimize these outcomes.
Comprehensive clinical evaluation
• Review your full medical history, including any childhood bone or dental problems.
• Physical exam focusing on bone tenderness, joint function and muscle strength.
Laboratory testing
• Serum alkaline phosphatase (ALP) level—persistently low in HPP.
• Vitamin B6 (pyridoxal-5′-phosphate), calcium, phosphate, and parathyroid hormone (PTH) levels.
• Rule out secondary causes of low ALP (e.g., malnutrition, liver disease).
Genetic testing
• Confirm ALPL gene variants to guide prognosis and family planning.
• Genetic counseling may help you understand inheritance and risks for children.
Imaging studies
• X-rays or CT scans to detect stress fractures, bone shape changes or osteoarthritis.
• Dual-energy X-ray absorptiometry (DXA) to assess bone mineral density trends over time.
Specialist referrals
• Metabolic bone disease specialist or endocrinologist for targeted therapy.
• Rheumatologist if joint inflammation is significant.
• Oral surgeon or dentist familiar with HPP-related dental care.
Symptom tracking
• Keep a daily log of pain levels, activity tolerance and any new issues.
• Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help organize your concerns before a medical visit.
Enzyme replacement therapy (ERT):
Asfotase alfa is the only approved ERT for HPP. It replaces deficient alkaline phosphatase, improving bone mineralization, reducing fractures and enhancing mobility.
Pain control and physical therapy:
• Non-opioid pain relievers (acetaminophen, NSAIDs) under physician guidance.
• Tailored exercise programs: low-impact activities (swimming, cycling) to maintain strength and flexibility.
• Balance training to reduce fall risk.
Dental care:
• Regular check-ups with an HPP-aware dentist.
• Avoid invasive procedures when possible; if needed, plan extractions with bone-healing protocols.
Nutritional support:
• Balanced diet with adequate protein, calcium and vitamin D—monitor levels carefully, as excess vitamin D or calcium may be harmful without proper enzyme function.
• Limit alcohol and caffeine, which can affect bone health.
Medication review:
• Avoid bisphosphonates, denosumab and other antiresorptives that can worsen HPP.
• Discuss all prescriptions and over-the-counter supplements with your doctor.
Regular follow-up is key to preventing symptom escalation:
Always speak to a doctor about anything that could be life-threatening or serious. Seek urgent care if you experience:
Understanding why hypophosphatasia in adulthood can escalate—and how to respond—helps you take charge of your health. By combining specialist care, appropriate therapies and lifestyle adjustments, many adults with HPP achieve significant relief and improved function.
Remember to keep your healthcare team informed about any new or worsening symptoms, and consider using a free, online symptom check, using the doctor approved Ubie Symptom Checker before appointments to ensure you cover all your concerns.
Above all, maintain open communication with your doctor and don’t hesitate to speak to a healthcare professional about any aspect of your care—especially if you suspect a serious or life-threatening issue.
(References)
* Mornet E. Hypophosphatasia. Best Pract Res Clin Rheumatol. 2008 Mar;22(1):113-27. doi: 10.1016/j.berh.2007.11.003. PMID: 18328985.
* Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Marini JC, Dang Do AN. Osteogenesis Imperfecta. 2000. PMID: 25905334.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. 2017 Jul 25. PMID: 28888853.
* Mornet E. Hypophosphatasia. Metabolism. 2018 May;82:142-155. doi: 10.1016/j.metabol.2017.08.013. 2017 Sep 20. PMID: 28939177.
* Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N, Wallon F, Rousseau N, Charle C, Guberto M, Muti C, Simon-Bouy B. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021 Feb;29(2):289-299. doi: 10.1038/s41431-020-00732-6. 2020 Sep 24. PMID: 32973344; PMCID: PMC7868366.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. 2021 Apr 30. PMID: 33931563.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Rush E, Brandi ML, Khan A, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Starling SR, Ward L, Yao L, Brignardello-Petersen R, Simmons JH. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024 Jan;35(1):1-10. doi: 10.1007/s00198-023-06843-2. 2023 Nov 20. PMID: 37982855; PMCID: PMC10786745.
* Brandi ML, Khan AA, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Roux C. The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance. Osteoporos Int. 2024 Mar;35(3):439-449. doi: 10.1007/s00198-023-06859-8. 2023 Nov 20. PMID: 37982856.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.